Addressing the Problem of Multidrug-Resistant Organisms in Dialysis.
作者信息
D'Agata Erika M C
机构信息
Division of Infectious Diseases, Rhode Island Hospital, Brown University, Providence, Rhode Island.
出版信息
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):666-668. doi: 10.2215/CJN.13781217. Epub 2018 Mar 22.
Abstract
摘要
相似文献
1
Addressing the Problem of Multidrug-Resistant Organisms in Dialysis.解决透析中多重耐药菌的问题。
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):666-668. doi: 10.2215/CJN.13781217. Epub 2018 Mar 22.
2
Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA).除耐甲氧西林金黄色葡萄球菌（MRSA）外，控制多重耐药菌的常见方法。
Infect Dis Clin North Am. 2011 Mar;25(1):181-200. doi: 10.1016/j.idc.2010.11.006. Epub 2010 Dec 17.
3
Implementing an antimicrobial stewardship program in out-patient dialysis units.在门诊透析单位实施抗菌药物管理计划。
Curr Opin Nephrol Hypertens. 2016 Nov;25(6):551-555. doi: 10.1097/MNH.0000000000000281.
4
Highly virulent pathogens--a post antibiotic era?高毒力病原体——抗生素后时代？
Br J Theatre Nurs. 1998 May;8(2):14-8. doi: 10.1177/175045899800800201.
5
Opportunities to Improve Antibiotic Prescribing in Outpatient Hemodialysis Facilities: A Report From the American Society of Nephrology and Centers for Disease Control and Prevention Antibiotic Stewardship White Paper Writing Group.改善门诊血液透析中心抗生素处方的机会：来自美国肾脏病学会和疾病控制与预防中心抗生素管理白皮书写作组的报告。
Am J Kidney Dis. 2021 May;77(5):757-768. doi: 10.1053/j.ajkd.2020.08.011. Epub 2020 Oct 10.
6
Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis.需要长期血液透析的患者中的多重耐药革兰氏阴性菌。
Clin J Am Soc Nephrol. 2008 May;3(3):752-8. doi: 10.2215/CJN.04651107. Epub 2008 Mar 5.
7
Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model.血液透析中心抗菌药物管理计划的临床和经济效益：决策分析模型。
Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1389-1397. doi: 10.2215/CJN.12521117. Epub 2018 Aug 23.
8
Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.万古霉素中介及耐药金黄色葡萄球菌。肾病科医生需要了解的内容。
Nephrol News Issues. 2004 Oct;18(11):63-4, 66-7, 71-2 passim.
9
Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.耐甲氧西林葡萄球菌的管理：预防耐药菌医院内传播的范例
Am J Infect Control. 2006 Jun;34(5 Suppl 1):S46-54: discussion S64-73. doi: 10.1016/j.ajic.2006.05.228.
10
Antimicrobial use and stewardship programs among dialysis centers.透析中心的抗菌药物使用及管理计划
Semin Dial. 2013 Jul-Aug;26(4):457-64. doi: 10.1111/sdi.12090. Epub 2013 Apr 22.
引用本文的文献
1
Secular trends of bloodstream infections in hemodialysis patients: insights from a longitudinal Swiss study.血液透析患者血流感染的长期趋势：来自瑞士一项纵向研究的见解
Antimicrob Resist Infect Control. 2025 Aug 20;14(1):100. doi: 10.1186/s13756-025-01620-8.
2
The contribution of community transmission to the burden of hospital-associated pathogens: A systematic scoping review of epidemiological models.社区传播对医院相关病原体负担的影响：流行病学模型的系统综述。
One Health. 2024 Dec 16;20:100951. doi: 10.1016/j.onehlt.2024.100951. eCollection 2025 Jun.
3
Colonisation with multidrug-resistant organisms among dialysis patients at Universitas Academic Hospital.比勒陀利亚大学学术医院透析患者中多重耐药菌的定植情况
S Afr J Infect Dis. 2024 Jul 9;39(1):607. doi: 10.4102/sajid.v39i1.607. eCollection 2024.
4
Management of Patients with Multidrug-Resistant Organisms in Outpatient Dialysis Facilities.门诊透析设施中耐多药生物体患者的管理
Clin J Am Soc Nephrol. 2023 Dec 27;19(5):656-9. doi: 10.2215/CJN.0000000000000419.
5
Stratifying nursing home care to further explore a locally validated risk factor for community-acquired pneumonia (SNAP-CAP Study).分层护理院护理以进一步探索社区获得性肺炎的本地验证风险因素（SNAP-CAP研究）。
Antimicrob Steward Healthc Epidemiol. 2023 Oct 27;3(1):e191. doi: 10.1017/ash.2023.466. eCollection 2023.
6
The cost of hospitalizations for treatment of hemodialysis catheter-associated blood stream infections in children: a retrospective cohort study.儿童血液透析导管相关血流感染治疗住院费用：一项回顾性队列研究。
Pediatr Nephrol. 2023 Jun;38(6):1915-1923. doi: 10.1007/s00467-022-05764-2. Epub 2022 Nov 3.
7
Chronic Kidney Disease-An Underestimated Risk Factor for Antimicrobial Resistance in Patients with Urinary Tract Infections.慢性肾脏病——尿路感染患者抗菌药物耐药性的一个被低估的危险因素。
Biomedicines. 2022 Sep 22;10(10):2368. doi: 10.3390/biomedicines10102368.
8
Patterns of microbial resistance in bloodstream infections of hemodialysis patients: a cross-sectional study from Palestine.血液透析患者血流感染中微生物耐药模式：来自巴勒斯坦的一项横断面研究。
Sci Rep. 2022 Oct 26;12(1):18003. doi: 10.1038/s41598-022-21979-7.
9
Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.血液透析导管封管液的抗菌活性与其他具有抗菌特性的化合物的关系。
PLoS One. 2021 Oct 7;16(10):e0258148. doi: 10.1371/journal.pone.0258148. eCollection 2021.
10
COVID-19 modeling and non-pharmaceutical interventions in an outpatient dialysis unit.COVID-19 建模和非药物干预在门诊透析单位。
PLoS Comput Biol. 2021 Jul 8;17(7):e1009177. doi: 10.1371/journal.pcbi.1009177. eCollection 2021 Jul.
Zotero 插件